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Brief Clinical ReportsThe embolus, removed 4 days from symptom onset, was
evaluated by using SEM, as previously described.3 Briefly,
after washing, the thrombus was fixed by means of perme-
ation with 2.5% glutaraldehyde and then treated with alco-
hol, dehydrated, gold coated, and photographed digitally
with a Hitachi S-4700 SEM (Hitachi, Tokyo, Japan).
The SEM images revealed that the inner parts of the re-
moved thrombus (Figure 1, B and C) are formed with tightly
packed, thick fibrin fibers resembling a solid mass; however,
in the very center there was cellular debris derived predom-
inantly from erythrocytes. At the periphery of the clot (Fig-
ure 1, D and E), a large amount of red blood cells embedded
in a relatively thin fibrin network with low amounts of plate-
let aggregates was visualized. No layered structure of the
embolus was observed.DISCUSSION
Contrary to the available scarce morphologic data,1 we did
not observe a layered thrombus structure. Compared with
thrombi removed from a coronary artery of patients with
acute myocardial infarction, which were fibrin rich with
erythrocytes and almost no platelets,4 the pulmonary throm-
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The Journal of Thoracic and Cafibrin and fewer red blood cells,whichwere presentmainly in
peripheral segments of the clot. The more compact the fibrin
fiber structure, the less susceptible to lysis,2 and not surpris-
ingly, such thrombi (Figure 1) are resistant to endogenous
fibrinolysis.
Thrombi from patients not receiving thromboprophylaxis
are likely even more dense, as seen at higher thrombin con-
centrations.5 Our findings might also help explain why fibri-
nolytic therapy might fail to rescue patients with large
pulmonary thrombi and comprised cardiopulmonary func-
tion, in whom embolectomy could be more effective.
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131-42.Pulmonary thromboendarterectomy in Klippel–Tre´naunay syndromeJonathan N. Johnson, MD,a David J. Driscoll, MD,a and Christopher G. A. McGregor, MB, FRCS, MD
(Hons),b Rochester, MinnChronic thromboembolic pulmonary hypertension
(CTEPH) occurs in 4% of patients with pulmonary embo-
lism (PE).1 Untreated, the likelihood of survival is poor.
Klippel–Tre´naunay syndrome (KTS) is a rare complex vas-
cular malformation that typically includes the triad of capil-
lary vascular malformation (port-wine stain), venous
malformation(s), and soft tissue or bony hypertrophy.2Patients with KTS are at increased risk for peripheral venous
thrombosis and pulmonary emboli.3 When medical manage-
ment of PE and CTEPH fails, pulmonary thromboendarter-
ectomy (PTE) is an important, potentially lifesaving
therapy.1CLINICAL SUMMARY
Three patients with KTS (2 women aged 19 and 46 years
and 1 man aged 26 years, Table 1) underwent PTE. The
patients had symptoms for an average of 9.6 months (range,
3–19 months) before surgery. Patient 2 had a diagnosis of
deep vein thrombosis before the CTEPH diagnosis. Patient
1 previously had a right arm amputation for complications
of vascular malformation. No patient had a clotting disorder.
Each patient had all 3 manifestations of KTS, including cap-
illary malformations, venous malformations, and soft tissue
hypertrophy.
A single surgeon performed all operations. The surgical
technique used was described by Jamieson and colleagues.1rdiovascular Surgery c Volume 140, Number 3 e41
TABLE 1. Demographic and procedural information for the three patients with Klippel–Tre´naunay syndrome who had pulmonary
thromboendarterectomy performed for chronic thromboembolic pulmonary hypertension at the Mayo Clinic College of Medicine
Patient
no.
Age
(y) Gender
Preoperative
DVT
Length
of stay (d) Complications
RVSP before
(mm Hg)*
RVSP after
(mm Hg)*
NYHA
before
NYHA
after
Available
follow-up (y)
1 19 F N 6 None 49 28 3 1 0.5
2 26 M Y 18 Stroke 69 68 3 2 6
3 46 F N 8 None 55 46 3 2 1.3
Postoperative NYHA class is listed as available from 6-month follow-up (short-term follow-up).DVT,Deep vein thrombosis; RVSP, right ventricular systolic pressure;NYHA,New
York Heart Association. *As measured by echocardiography.
Brief Clinical ReportsAll patients had preoperative inferior vena cava filter place-
ment, pulmonary angiography, and preoperative and postop-
erative echocardiography. Each of the 3 patients underwent
bilateral PTE (Figure 1).
All patients were monitored intraoperatively and postop-
eratively with pulmonary artery catheters. Main pulmonary
artery pressures under similar hemodynamic conditions de-
creased from 46 11.5 mm Hg pre-procedure to 24.3 6.7
mm Hg post-procedure (P ¼ .047). The echocardiography-
measured right ventricular systolic pressure decreasedFIGURE 1. Fully dissected organized thrombus taken from the right pul-
monary arterial tree of patient 1.
e42 The Journal of Thoracic and Cardiovascular Surgfrom 49 to 28 mm Hg in patient 1 and from 55 to 46 mm
Hg in patient 3, but did not change in patient 2 (69 to 68
mm Hg, Table 1). Echocardiography-assessed right ventric-
ular function improved in all 3 patients.
The average estimated blood loss was 1273  629 mL
(range, 900–2000 mL). All 3 patients had blood transfu-
sions and intraoperative surgical blood cell salvage (‘‘Cell
Saver’’) transfusions intraoperatively. Cardiopulmonary
bypass was used for an average of 265 35 minutes (range,
237–304 minutes) with circulatory arrest for an average of
44  12 minutes (range, 37–58 minutes). Chest tubes
were placed in all patients, with an average output of
517 mL (range, 340–705 mL), and were removed after an
average of 3 days (range, 1–6 days). Patients 1 and 3 had
a hospital length of stay of 6 and 8 days, respectively,
and had no complications. Patient 2 was in the hospital
for 18 days secondary to a postoperative stroke, consisting
of left upper-extremity weakness. He also had recurrent
postoperative pleural effusions, necessitating repeat chest
tube placement. At the time of discharge, all effusions
had resolved, and the patient’s weakness was improving
with therapy.
There were no deaths. All patients reported marked symp-
tomatic relief postoperatively. All patients were treated with
long-term anticoagulation postoperatively. Inferior vena
cava filters were not removed in any of the 3 patients. Aver-
age available follow-up is 2.6 years (range, 0.5–6). No pa-
tient has had a postoperative deep vein thrombosis or PE.
Patient 2, while symptomatically improving, had no signifi-
cant change in pulmonary pressures postoperatively.DISCUSSION
We report 3 patients with KTS who had recurrent
pulmonary emboli and CTEPH, all of whom had a PTE
performed. Surgery in patients with KTS is high risk, par-
ticularly with associated risks of hemorrhage, infection,
and thrombosis.3 One of our 3 patients had a complication:
Patient 2 had a stroke and recurrent CTEPH despite
thromboendarterectomy.
The use of PTE in patients with KTS was first reported in
1991.4 A 53-year-old man with KTS and CTEPH underwent
a successful PTE, but he died 10 days postoperatively sec-
ondary to recurrent massive PE. In 2000, a 24-year-oldery c September 2010
Brief Clinical Reportsman was described with failure of medical treatment for re-
current pulmonary emboli.5 PTE was successfully per-
formed, with no recurrence of CTEPH at the 7-month
follow-up. An 11-year-old boy was reported to have under-
gone pulmonary thromboendarterectomy (Huiras and col-
leagues3), but he died after recurrent PE.
CONCLUSIONS
PTE is a difficult operation to perform. The procedure was
developed and advanced by Jamieson and colleagues.1 As
experience with the technique has grown, many centers
have seen mortality decrease to less than 5%. There are 3
previously reported cases of PTE performed for KTS, but
2 of the patients died after surgery.3-5 PTE should be per-
formed only by surgeons who are experienced with theFrom the Departments of Cardiovascular Surgery B,a Digestive Surgery,b and Radiol-
ogy,c University Hospital of Rangueil,b Toulouse, France.
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The Journal of Thoracic and Caoperation. In selected patients, PTE can be an effective
and potentially lifesaving curative procedure, and it is an im-
portant therapeutic option in patients with CTEPH.References
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117:1520-2.Successful surgery for atrioesophageal fistula caused by transcatheter
ablation of atrial fibrillationAlexandre Cazavet, MD,a Fabrice Muscari, MD,b Marie Agne`s Marachet, MD,c and
Bertrand Le´obon, MD, PhD,a Toulouse, FranceCatheter ablation (CA) is an effective and safe technique to
treat atrial fibrillation; however, it can cause rare but lethal
complications.1 Atrioesophageal fistula (AEF) caused by
diffusion of the ablative energy through the left atrial wall
to the esophagus (because of the absence of pericardium)
is lethal if not treated surgically.
CLINICAL SUMMARY
A 35-year-old man had a 3-year history of atrial fibrilla-
tion that had been permanent for the last 2 years. Amiodar-
one had proven ineffective, and an electrical cardioversion
failed. Echocardiography showed the left side of his heart
(left ventricular ejection fraction, 60%) to be preserved
with a left atrial diameter of 27 mm. CA performed at an-
other institution was uneventful, and the patient was dis-
charged the next day in sinus rhythm.Thirty-eight days later, the patient had fever, chest pain,
and vomiting and was urgently admitted to a peripheral hos-
pital, where he presented a left hemiplegia and convulsive
crisis. There was no early lesion observed on cerebral com-
puted tomography (CT) scan. Blood cultures were positive
for streptococcus salivarius, transthoracic echocardiography
showed no evidence of endocarditis, and lumbar puncture re-
sults were unremarkable. A specific antibiotic therapy was
initiated, and the patient was transferred to the University
Hospital of Rangueil. Cerebral magnetic resonance imaging
showed widespread ischemic changes consistent with multi-
ple emboli, and CT scan showed cerebral, splenic, and renal
emboli associated with the presence of air within the medias-
tinum and left atrium, suggesting an AEF (Figure 1).
Because of the patient’s poor condition, a silicone-covered
stent was initially placed in the esophagus under radioscopy
to seal off the AEF, but the stent migrated into the stomach
a few hours later.
Surgery was performed via a left thoracotomy because of
a left pleural effusion. The left femoral vessels were accessi-
ble, and a cardiopulmonary bypass was on standby. After
careful dissection, the AEF was identified and the esophagus
was separated from the left atrial wall. A preventive suture
was done on the atrial wall despite the absence of perfora-
tion. The esophageal perforation (Figure 2, B) was closed us-
ing adsorbable monofilament sutures. A pediculated
autologous pericardial patch was then placed between therdiovascular Surgery c Volume 140, Number 3 e43
